Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

Abstract

Heart disease was more common in those who did not receive bevacizumab. Older patients who receive bevacizumab with chemotherapy have a higher odds of developing a grade 3-5 toxicity compared with those who receive chemotherapy alone.